GC Investment Information
As a global leader of the health industry
Through a variety of business
Moving the corporate value.
Total Number of Shares(as of the end of 2017) Unit: Number of shares
| Type | Common stock | Preferred stock | Total |
|---|---|---|---|
| Total issued | 47,028,210 | 2,514,860 | 49,543,070 |
| Treasury stock | 2,094,020 | 2,047,319 | 4,141,339 |
| In circulation | 44,934,190 | 467,541 | 45,401,731 |
| Type | Stock type | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|
| Face price per share (KRW) | 500 | 500 | 500 | |
| (Consolidated) net income (in KRW million) | 18,467 | 43,364 | 47,177 | |
| (Separate) net income (in KRW million) | 19,511 | 20,576 | 26,794 | |
| (Consolidated) net income per share (KRW) | 406 | 955 | 1,039 | |
| Total payout in cash (in KRW million) | 11,352 | 13,622 | 13,622 | |
| (Consolidated) propensity to cash payout (%) | 61.5 | 31.4 | 28.9 | |
| Cash dividend yield ratio (%) |
Common stock | 1.0 | 0.8 | 1.3 |
| Preferred stock | - | - | 1.3 | |
| Weekly Cash dividend ratio (KRW) |
Common stock | 250 | 300 | 300 |
| Preferred stock | 255 | 305 | 305 | |
-
- GC MS
- GC Wellbeing
- GCMedis
-
- Overseas
- GC China Pharm
- Curevo
- GC Pharma do Brasil
-
- Foundation
- MOGAM Institue
- GC Labs
- GC i-Med
-
- Others
- GC Invacfarm